Home › Funds › BNY Mellon › BNY Mellon US Small Cap Core Equity ETF
Fund family: BNY Mellon · Filed by BNY Mellon ETF Trust (CIK 1493580) · SEC series S000067262
Ticker: BKSE (C000216364)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 5,332 with, 28 against, 0 abstentions (not counted as with management). Shareholder proposals: 7 FOR, 19 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as BNY Mellon’s manager page (141,760 ballot items across 60 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | BNY Mellon | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 90.6% | 5,209 | 93.1% | 117,600 |
| Backed environmental and social shareholder proposals at US companies | n/a | 6 | 1.8% | 1,473 |
Each ballot item this fund voted is set against the votes of the other BNY Mellon funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most BNY Mellon funds on 67 items (4.4% of the 1,507 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most BNY Mellon funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| JFrog Ltd. | 2026-05-20 | Election of Directors: Elisa Steele | Against | FOR — 7 of 7 BNY Mellon funds | Against | Passed (calculated), 70.7% support |
| JFrog Ltd. | 2026-05-20 | Election of Directors: Yossi Sela | For | AGAINST — 7 of 7 BNY Mellon funds | For | Passed (calculated), 95.9% support |
| Mirum Pharmaceuticals, Inc. | 2026-06-15 | To elect the Board's three Class I nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Lon Cardon, Ph.D., FMedSci | Withhold | FOR — 5 of 5 BNY Mellon funds | Against | Elected, 85.3% support |
| Mirum Pharmaceuticals, Inc. | 2026-06-15 | To elect the Board's three Class I nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: William Fairey | Withhold | FOR — 5 of 5 BNY Mellon funds | Against | Elected, 86.8% support |
| The Baldwin Insurance Group, Inc. | 2026-06-04 | Company Proposal - To elect four Class I Directors to serve until the 2029 Annual Meeting of Shareholders or until their successors are duly elected and qualified: Ellyn Shook | Withhold | FOR — 5 of 5 BNY Mellon funds | Against | Elected, 82.2% support |
| Alignment Healthcare, Inc. | 2026-06-04 | Election of Directors: Jacqueline Kosecoff | Withhold | FOR — 5 of 5 BNY Mellon funds | Against | Elected, 76.1% support |
| Alignment Healthcare, Inc. | 2026-06-04 | Election of Directors: Jody Bilney | Withhold | FOR — 5 of 5 BNY Mellon funds | Against | Elected, 76.1% support |
| Rhythm Pharmaceuticals, Inc. | 2026-06-24 | Election of the Class III directors, each to serve for a three year term until the 2029 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: David W.J. McGirr | Withhold | FOR — 4 of 4 BNY Mellon funds | Against | Passed (calculated), 85.9% support |
| Viking Therapeutics, Inc. | 2026-05-19 | TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS. | For | AGAINST — 4 of 4 BNY Mellon funds | For | Approved, 70.2% support |
| Weatherford International plc | 2026-06-11 | Scheme Related Business If the Scheme of Arrangement proposal is approved at the Court Meeting: To approve the Scheme of Arrangement by, and on behalf of, Weatherford International plc ("Weatherford-Ireland') and to authorize the directors of Weatherford-Ireland to take all such actions as they cons | Against | FOR — 6 of 7 BNY Mellon funds | Against | Passed (calculated), 61.0% support |
| Weatherford International plc | 2026-06-11 | To agree to a scheme of arrangement under Chapter 1 of Part 9 of the Companies Act 2014, as amended, substantially in the form attached as Annex C to the Proxy Statement, that, once it becomes effective, will result in you owning common stock of Weatherford International Corp Instead of ordinary sha | Against | FOR — 6 of 7 BNY Mellon funds | Against | — |
| Weatherford International plc | 2026-06-11 | To approve a capital reduction under sections 84 to 86 of the Companies Act to effect the cancellation of Weatherford-Ireland ordinary shares contemplated by the Scheme of Arrangement. | Against | FOR — 6 of 7 BNY Mellon funds | Against | Passed (calculated), 63.9% support |
| Weatherford International plc | 2026-06-11 | To approve an amendment to the Weatherford-Ireland Articles so that any Weatherford-Ireland ordinary shares that are issued on or after the Voting Record Time to persons other than Weatherford-US or its nominee(s) will either be subject to the terms of the Scheme of Arrangement or will be immediatel | Against | FOR — 6 of 7 BNY Mellon funds | Against | Passed (calculated), 61.0% support |
| Weatherford International plc | 2026-06-11 | To approve any motion to adjourn the AGM, or any adjournments thereof, to another time and place if necessary or appropriate to solicit additional proxies if there are insufficient votes at the time of the AGM to approve the resolutions proposed at the AGM. | Against | FOR — 6 of 7 BNY Mellon funds | Against | — |
| Weatherford International plc | 2026-06-11 | To approve the terms of an initial subscription, allotment and issue of one, or more, Weatherford-Ireland ordinary shares to Weatherford International Corp ("Weatherford-US") in connection with the Scheme of Arrangement. | Against | FOR — 6 of 7 BNY Mellon funds | Against | Passed (calculated), 64.7% support |
| Weatherford International plc | 2026-06-11 | To authorize the directors of Weatherford-Ireland to allot and issue further new Weatherford-Ireland ordinary shares to Weatherford-US in connection with the Scheme of Arrangement to be paid up by the application of certain reserves as described in the Scheme of Arrangement. | Against | FOR — 6 of 7 BNY Mellon funds | Against | Passed (calculated), 66.3% support |
| Synaptics Incorporated | 2025-10-28 | Proposal for the Election of Directors: Patricia Kummrow | Against | FOR — 6 of 7 BNY Mellon funds | Against | Elected, 90.0% support |
| Synaptics Incorporated | 2025-10-28 | Proposal to approve the Company's amended and restated 2019 Equity and Incentive Compensation Plan. | Against | FOR — 6 of 7 BNY Mellon funds | Against | Approved, 67.7% support |
| YETI Holdings, Inc. | 2026-05-07 | Election of four Class II directors: Arne Arens | Withhold | FOR — 6 of 7 BNY Mellon funds | Against | Elected, 75.5% support |
| YETI Holdings, Inc. | 2026-05-07 | Election of four Class II directors: Mary Lou Kelley | Withhold | FOR — 6 of 7 BNY Mellon funds | Against | Elected, 66.7% support |
| Transocean Ltd. | 2026-05-22 | Election of 11 Directors, Each for a Term Extending Until Completion of the Next Annual General Meeting: Frederico F. Curado | For | AGAINST — 3 of 3 BNY Mellon funds | For | Elected, 87.2% support |
| Transocean Ltd. | 2026-05-22 | Ratification of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm for Fiscal Year 2026 and Reelection of Ernst & Young Ltd, Zurich, as the Company's Auditor for a Further One Year Term | For | AGAINST — 3 of 3 BNY Mellon funds | For | — |
| Disc Medicine, Inc. | 2026-06-18 | To elect each of the following Class III nominees to the Board of Directors as set forth below: Class III Nominees: Donald Nicholson, Ph.D. | Withhold | FOR — 3 of 3 BNY Mellon funds | Against | Passed (calculated), 84.2% support |
| PennyMac Financial Services, Inc. | 2026-06-03 | To elect the ten (10) director nominees identified in the enclosed Proxy Statement to serve on our Board of Directors, each for a one-year term expiring at the 2027 Annual Meeting of Stockholders: Doug Jones | Against | FOR — 3 of 3 BNY Mellon funds | Against | Passed (calculated), 99.5% support |
| GeneDx Holdings Corp. | 2026-06-18 | Election of Director: Katherine Stueland | Withhold | FOR — 3 of 3 BNY Mellon funds | Against | Passed (calculated), 75.7% support |
| Company | Meeting | Item | This fund | Most BNY Mellon funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| The Timken Company | 2026-05-08 | Shareholder Consideration of a shareholder proposal asking our Board of Directors to take the steps necessary to amend the appropriate Company governing documents to give the owners of a combined 10% of our outstanding common stock the power to call a special shareholder meeting or the owners of the lowest perc | Against | FOR — 4 of 5 BNY Mellon funds | For | Not approved, 41.4% support |
| The Timken Company | 2026-05-08 | Ratification of the appointment of Ernst & Young LLP as our independent auditor for the fiscal year ending December 31, 2026. | For | AGAINST — 4 of 5 BNY Mellon funds | For | Passed (calculated), 96.9% support |
| EnerSys | 2025-07-31 | Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for fiscal year ending March 31, 2026. | For | AGAINST — 4 of 5 BNY Mellon funds | For | Approved, 96.0% support |
| Brunswick Corporation | 2026-05-06 | The Election to Brunswick's Board of Directors of the ten nominees named in the Proxy Statement: David C. Everitt | For | AGAINST — 4 of 5 BNY Mellon funds | For | — |
| Visteon Corporation | 2026-06-11 | Elect the eight director nominees named in the proxy statement to hold office until the next annual stockholders' meeting: Robert J. Manzo | For | AGAINST — 4 of 5 BNY Mellon funds | For | Passed (calculated), 94.3% support |
| Bank OZK | 2026-05-18 | Election of Directors: Nicholas Brown | For | AGAINST — 4 of 5 BNY Mellon funds | For | — |
| Rhythm Pharmaceuticals, Inc. | 2026-06-24 | Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company. | For | AGAINST — 5 of 7 BNY Mellon funds | For | Approved, 81.5% support |
| Moelis & Company | 2026-06-25 | Election of Directors: Eric Cantor | Against | FOR — 5 of 7 BNY Mellon funds | Against | Passed (calculated), 97.8% support |
| Moelis & Company | 2026-06-25 | Election of f Directors: Louise Mirrer | Against | FOR — 5 of 7 BNY Mellon funds | Against | Passed (calculated), 84.0% support |
| Mirum Pharmaceuticals, Inc. | 2026-06-15 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. | For | AGAINST — 6 of 9 BNY Mellon funds | For | Approved, 96.0% support |
| Darling Ingredients Inc. | 2026-05-07 | Ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending January 2, 2027. | For | AGAINST — 4 of 6 BNY Mellon funds | For | Passed (calculated), 92.2% support |
| Americold Realty Trust, Inc. | 2026-05-18 | Shareholder Advisory Vote on Shareholder Proposal Regarding Director Removal With or Without Cause. | Against | FOR — 3 of 4 BNY Mellon funds | For | Passed (calculated), 61.8% support |
| Belden Inc. | 2026-05-21 | Ratification of the appointment of Ernst & Young as the Company's Independent Registered Public Accounting Firm for 2026. | For | AGAINST — 3 of 4 BNY Mellon funds | For | Passed (calculated), 96.7% support |
| COPT Defense Properties | 2026-05-14 | Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the current fiscal year. | For | AGAINST — 3 of 4 BNY Mellon funds | For | — |
| RH | 2026-06-18 | Election of Directors: Ali Rowghani | Withhold | FOR — 3 of 4 BNY Mellon funds | Against | Passed (calculated), 94.5% support |
| John Wiley & Sons, Inc. | 2025-09-25 | The election as directors of all nominees listed below, except as marked to the contrary: Brian O. Hemphill | Withhold | FOR — 4 of 6 BNY Mellon funds | Against | Plurality election, 45.6% support |
| Texas Capital Bancshares, Inc. | 2026-04-21 | To adjourn the Annual Meeting to a later date or dates, if necessary, to solicit additional proxies if there are insufficient votes to adopt any of Proposals 2-5; and | For | AGAINST — 3 of 4 BNY Mellon funds | For | Not approved, 31.1% support |
| Texas Capital Bancshares, Inc. | 2026-04-21 | To approve the redomestication of the Company from Delaware to Texas by way of conversion; | For | AGAINST — 3 of 4 BNY Mellon funds | For | Not approved, 45.2% support |
| Texas Capital Bancshares, Inc. | 2026-04-21 | To approve, on an advisory basis, increasing the threshold to submit stockholder proposals; | For | AGAINST — 3 of 4 BNY Mellon funds | For | Not approved, 12.9% support |
| Texas Capital Bancshares, Inc. | 2026-04-21 | To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026; | For | AGAINST — 3 of 4 BNY Mellon funds | For | Approved, 98.3% support |
| Lumentum Holdings Inc. | 2025-11-19 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. | For | AGAINST — 5 of 9 BNY Mellon funds | For | Passed (calculated), 88.9% support |
| Southwest Gas Holdings, Inc. | 2026-05-07 | To APPROVE, on a non-binding, advisory basis, the Company's executive compensation. | For | AGAINST — 5 of 9 BNY Mellon funds | For | Passed (calculated), 97.7% support |
| Blackbaud, Inc. | 2026-06-10 | ADVISORY VOTE TO APPROVE THE 2025 COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. | For | AGAINST — 5 of 9 BNY Mellon funds | For | Approved, 98.3% support |
| GeneDx Holdings Corp. | 2026-06-18 | Approval, on a non-binding advisory basis, the compensation of our named executive officers. | For | AGAINST — 4 of 7 BNY Mellon funds | For | Passed (calculated), 93.9% support |
| Arrow Electronics, Inc. | 2026-05-12 | To approve, by non-binding vote, named executive officer compensation. | For | AGAINST — 3 of 5 BNY Mellon funds | For | — |
| Meritage Homes Corporation | 2026-05-21 | Shareholder Shareholder proposal to improve shareholder ability to call for a special shareholder meeting. | Against | FOR — 3 of 5 BNY Mellon funds | For | Not approved, 25.6% support |
| United Community Banks, Inc. | 2026-05-13 | Election of Directors: Thomas A. Richlovsky | For | WITHHOLD — 3 of 5 BNY Mellon funds | For | Elected, 96.0% support |
| Magnite, Inc. | 2026-06-08 | Approval, on an advisory basis, of the compensation of the Company's named executive officers. | For | AGAINST — 3 of 5 BNY Mellon funds | For | Approved, 89.2% support |
| Hayward Holdings, Inc. | 2026-05-21 | Election of Directors: Arthur Soucy | Withhold | FOR — 3 of 5 BNY Mellon funds | Against | Elected, 65.3% support |
| Hayward Holdings, Inc. | 2026-05-21 | Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2026. | For | AGAINST — 3 of 5 BNY Mellon funds | For | Passed (calculated), 97.7% support |
| Simmons First National Corporation | 2026-05-13 | To ratify the Audit Committee's selection of the accounting firm Forvis Mazars, LLP as independent auditors of the Company and its subsidiaries for the year ending December 31, 2026. | For | AGAINST — 3 of 5 BNY Mellon funds | For | Passed (calculated), 95.8% support |
| BankUnited, Inc. | 2026-05-21 | To approve the BankUnited, Inc. Amended and Restated 2023 Omnibus Equity Incentive Plan. | For | AGAINST — 3 of 5 BNY Mellon funds | For | Passed (calculated), 60.2% support |
| SkyWest, Inc. | 2026-05-05 | Shareholder A shareholder proposal regarding collective bargaining policy. | Against | FOR — 3 of 5 BNY Mellon funds | For | — |
| Patrick Industries, Inc. | 2026-05-14 | To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: John A. Forbes | For | WITHHOLD — 3 of 5 BNY Mellon funds | For | Elected, 92.6% support |
| Patrick Industries, Inc. | 2026-05-14 | To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: Joseph M. Cerulli | For | WITHHOLD — 3 of 5 BNY Mellon funds | For | Elected, 83.6% support |
| LCI Industries | 2026-05-12 | To ratify the appointment of KPMG LLP as independent auditor for the Company for the year ending December 31, 2026. | For | AGAINST — 3 of 5 BNY Mellon funds | For | Passed (calculated), 96.7% support |
| Littelfuse, Inc. | 2026-04-22 | Election of Directors: Maria C. Green | Against | FOR — 2 of 3 BNY Mellon funds | Against | Passed (calculated), 93.9% support |
| The Hanover Insurance Group, Inc. | 2026-05-12 | The ratification of the appointment of PricewaterhouseCoopers LLP to serve as the Company's independent, registered public accounting firm for 2026. | For | AGAINST — 2 of 3 BNY Mellon funds | For | Passed (calculated), 97.7% support |
| CNO Financial Group, Inc. | 2026-05-12 | Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for 2026. | For | AGAINST — 2 of 3 BNY Mellon funds | For | Approved, 97.9% support |
| The Boston Beer Company, Inc. | 2026-05-27 | Election of Directors: Cynthia L. Swanson | Withhold | FOR — 2 of 3 BNY Mellon funds | Against | — |
| The Boston Beer Company, Inc. | 2026-05-27 | Election of Directors: Joseph H. Jordan | Withhold | FOR — 2 of 3 BNY Mellon funds | Against | — |
| The Boston Beer Company, Inc. | 2026-05-27 | Election of Directors: Meghan V. Joyce | Withhold | FOR — 2 of 3 BNY Mellon funds | Against | — |
Download all 67 differences (CSV)
The same votes as “with management” above, by the sector of the company voted on. 96.3% of this fund’s 5,360 such votes could be given a sector; the other 197 (3.7%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Consumer Discretionary | 1,193 | 17 | 1.4% |
| Finance | 1,032 | 0 | 0.0% |
| Industrials | 675 | 5 | 0.7% |
| Technology | 642 | 4 | 0.6% |
| Health Care | 557 | 1 | 0.2% |
| Real Estate | 326 | 1 | 0.3% |
| Energy | 279 | 0 | 0.0% |
| Utilities | 196 | 0 | 0.0% |
| Consumer Staples | 83 | 0 | 0.0% |
| Miscellaneous | 82 | 0 | 0.0% |
| Basic Materials | 57 | 0 | 0.0% |
| Telecommunications | 41 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 3,786 | 2 |
| Say-on-Pay | 617 | 2 |
| Audit-related | 580 | 0 |
| Compensation | 176 | 0 |
| Corporate Governance | 131 | 17 |
| Extraordinary Transactions | 53 | 0 |
| Capital Structure | 50 | 0 |
| Shareholder Rights and Defenses | 11 | 1 |
| Environment or Climate | 2 | 2 |
| Human Rights or Human Capital/workforce | 2 | 2 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Sandisk Corporation | November 18, 2025 | $3M | 10 | 0 |
| Lumentum Holdings Inc. | November 19, 2025 | $1M | 11 | 0 |
| Nextracker Inc. | August 18, 2025 | $735,289 | 5 | 0 |
| Glaukos Corporation | May 28, 2026 | $490,994 | 4 | 0 |
| Modine Manufacturing Company | August 21, 2025 | $406,415 | 6 | 0 |
| e.l.f. Beauty, Inc. | August 21, 2025 | $400,893 | 5 | 0 |
| Columbia Banking System, Inc. | July 21, 2025 | $393,226 | 2 | 0 |
| Cirrus Logic, Inc. | July 29, 2025 | $386,365 | 9 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| May 12, 2026 | Arrow Electronics, Inc. | Shareholder proposal to provide shareholders with the ability to call a special shareholder meeting at a 10% ownership threshold. Shareholder proposal | Against | For |
| June 9, 2026 | Etsy, Inc. | Advisory vote on a stockholder proposal to govern by majority vote. Shareholder proposal | For | Against |
| March 9, 2026 | Sanmina Corporation | To consider and vote upon the stockholder proposal entitled "Independent Board Chairman," requesting that the Board of Directors adopt a policy and amend governing documents as necessary in order that two separate people hold the office of the Chairman and the office of the CEO. Shareholder proposal | Against | For |
| May 8, 2026 | The Timken Company | Consideration of a shareholder proposal asking our Board of Directors to take the steps necessary to amend the appropriate Company governing documents to give the owners of a combined 10% of our outstanding common stock the power to call a special shareholder meeting or the owners of the lowest percentage of shareholders, as governed by state law, the power to call a special shareholder meeting. Shareholder proposal | Against | For |
| May 14, 2026 | Wyndham Hotels & Resorts, Inc. | To vote on a stockholder proposal, if properly presented at the meeting, regarding stockholder ability to act by written consent. Shareholder proposal | For | Against |
| April 28, 2026 | The Brink's Company | Act upon a shareholder proposal requesting a report on employee retention rates by demographic categories. Shareholder proposal | Against | For |
| April 15, 2026 | Sonoco Products Company | Advisory (non-binding) shareholder proposal - avoid brand damage from political spending. Shareholder proposal | Against | For |
| May 18, 2026 | Americold Realty Trust, Inc. | Advisory Vote on Shareholder Proposal Regarding Director Removal With or Without Cause. Shareholder proposal | Against | For |
| May 21, 2026 | Meritage Homes Corporation | Shareholder proposal to improve shareholder ability to call for a special shareholder meeting. Shareholder proposal | Against | For |
| May 4, 2026 | Asbury Automotive Group, Inc. | Stockholder proposal regarding special stockholder meetings. Shareholder proposal | Against | For |
| May 13, 2026 | ICU Medical, Inc. | To approve, on an advisory basis, a stockholder proposal to establish a 10% stockholder special meeting right. Shareholder proposal | Against | For |
| May 21, 2026 | Harley-Davidson, Inc. | To vote on a shareholder proposal regarding a climate transition plan. Shareholder proposal | Against | For |
Meetings with a proxy contest or competing nominees (4 in 2025-2026), and how the fund voted the items on its ballot.
5,411 ballot items at 621 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, BNY Mellon US Small Cap Core Equity ETF (BKSE) voted at 621 shareholder meetings of 594 companies, on 5,411 ballot items in all. Where management made a recommendation, the fund followed it on 99.5% of the items and voted against it 28 times. Its most frequent area of disagreement was corporate governance (17 of its votes against management). It voted on 27 shareholder proposals. It voted FOR the board's own proposals less often than BNY Mellon's funds as a whole (90.6% against 93.1%). It voted differently from most BNY Mellon funds on 67 items. 4 of its meetings were contested.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of BNY Mellon’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.